Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related Surgery

Author： Souverein P.C.   Erkens J.A.   de la Rosette J.J.M.C.H.   Leufkens H.G.M.   Herings R.M.C.  

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.43, Iss.5, 2003-05, pp. : 528-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Benign Prostatic Hyperplasia in Scandinavia: A Hospital Questionnaire on Pretreatment Evaluation and Treatment

By Jensen Klaus M.-E.   Hedlund Hans  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 1, 1998-05 ,pp. : 26-32

Informa Healthcare

Access to resources Recommend Favorite

Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia

By Kusek J.W.   Ahrens A.   Burrows P.K.   Clarke H.S.   Foster H.E.   Hanson K.   Jacobs S.C.   Kirkemo A.   O'Berry K.   Pavlik V.N.   for the MTOPS Research Group  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

Laser treatment of benign prostatic hyperplasia

By Kuntz Rainer  

World Journal of Urology, Vol. 25, Iss. 3, 2007-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Lasers in the treatment of benign prostatic hyperplasia

By Gerber G.S.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

Caspases are involved in benign prostatic hyperplasia (BPH) induced apoptosis by finasteride

By Bozec A.   Ruffion A.   Decaussin M.   Devonec M.   Benahmed M.   Mauduit C.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 85-85

Elsevier

Access to resources Recommend Favorite